Tetratherix (TTX) Stock Overview

Engages in biomaterial and regenerative medicine business in Australia and internationally. More details

TTX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Rewards

Revenue is forecast to grow 38.56% per year

Revenue grew by 8.5% over the past year

Risk Analysis

Makes less than USD$1m in revenue (A$777K)

Shares are highly illiquid

Negative shareholders equity

Has less than 1 year of cash runway

+ 2 more risks

TTX Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Tetratherix Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tetratherix
Historical stock prices
Current Share Price	AU$3.80
52 Week High	AU$4.44
52 Week Low	AU$3.30
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	5.56%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	TTX	AU Biotechs	AU Market
7D	6.7%	7.2%	2.2%
1Y	n/a	-14.2%	8.9%

Return vs Industry: Insufficient data to determine how TTX performed against the Australian Biotechs industry.

Return vs Market: Insufficient data to determine how TTX performed against the Australian Market.

Price Volatility

Is TTX's price volatile compared to industry and market?
TTX volatility
TTX Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.9%
Market Average Movement	9.0%
10% most volatile stocks in AU Market	18.1%
10% least volatile stocks in AU Market	3.1%

Stable Share Price: TTX's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: Insufficient data to determine TTX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2015	n/a	Will Knox	tetratherix.com

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company has used its Tetramatrix platform technology to manufacture and provide products in the areas of bone regeneration, tissue spacing, and tissue healing applications. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.

Tetratherix Limited Fundamentals Summary

How do Tetratherix's earnings and revenue compare to its market cap?
TTX fundamental statistics
Market cap	AU$191.26m
Earnings (TTM)	-AU$5.27m
Revenue (TTM)	AU$776.95k

246.2x

P/S Ratio

-36.3x

P/E Ratio

Is TTX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TTX income statement (TTM)
Revenue	AU$776.95k
Cost of Revenue	AU$1.68m
Gross Profit	-AU$900.50k
Other Expenses	AU$4.37m
Earnings	-AU$5.27m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.10
Gross Margin	-115.90%
Net Profit Margin	-678.07%
Debt/Equity Ratio	-211.4%

How did TTX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/07/18 07:48
End of Day Share Price	2025/07/18 00:00
Earnings	2024/12/31
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tetratherix Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Melissa Benson	Barrenjoey Markets Pty Limited
Scott Power	Morgans Financial Limited